AIMS: Chronic hypoxia (CH) enhances depolarization-induced myofilament Ca(2+) sensitization and resultant pulmonary arterial constriction through superoxide (O(2)(-))-dependent stimulation of RhoA. Because NAD(P)H oxidase (NOX) has been implicated in the development of pulmonary hypertension, we hypothesized that vascular smooth muscle (VSM) depolarization increases NOX-derived O(2)(-) production leading to myofilament Ca(2+) sensitization and augmented vasoconstrictor reactivity following CH. As epidermal growth factor receptor (EGFR) mediates Rac1-dependent NOX activation in renal mesangial cells, we further sought to examine the role EGFR plays in this response. RESULTS: Vasoconstrictor responses to depolarizing concentrations of KCl were greater in lungs isolated from CH (4 wk, 0.5 atm) rats compared to normoxic controls, and this effect of CH was abolished by the general NOX inhibitor, apocynin. CH similarly augmented KCl-induced vasoconstriction and O(2)(-) generation (assessed using the fluorescent indicator, dihydroethidium) in Ca(2+)-permeabilized, pressurized small pulmonary arteries. These latter responses to CH were prevented by general inhibition of NOX isoforms (apocynin, diphenylene iodonium), and by selective inhibition of NOX 2 (gp91ds-tat), Rac1 (NSC 23766), and EGFR (AG 1478). Consistent with these observations, CH increased KCl-induced EGFR phosphorylation, and augmented depolarization-induced Rac1 activation in an EGFR-dependent manner. INNOVATION: This study establishes a novel signaling axis in VSM linking membrane depolarization to contraction that is independent of Ca(2+) influx, and which mediates myofilament Ca(2+) sensitization in the hypertensive pulmonary circulation. CONCLUSION: CH augments membrane depolarization-induced pulmonary VSM Ca(2+) sensitization and vasoconstriction through EGFR-dependent stimulation of Rac1 and NOX 2.
AIMS: Chronic hypoxia (CH) enhances depolarization-induced myofilament Ca(2+) sensitization and resultant pulmonary arterial constriction through superoxide (O(2)(-))-dependent stimulation of RhoA. Because NAD(P)H oxidase (NOX) has been implicated in the development of pulmonary hypertension, we hypothesized that vascular smooth muscle (VSM) depolarization increases NOX-derived O(2)(-) production leading to myofilament Ca(2+) sensitization and augmented vasoconstrictor reactivity following CH. As epidermal growth factor receptor (EGFR) mediates Rac1-dependent NOX activation in renal mesangial cells, we further sought to examine the role EGFR plays in this response. RESULTS: Vasoconstrictor responses to depolarizing concentrations of KCl were greater in lungs isolated from CH (4 wk, 0.5 atm) rats compared to normoxic controls, and this effect of CH was abolished by the general NOX inhibitor, apocynin. CH similarly augmented KCl-induced vasoconstriction and O(2)(-) generation (assessed using the fluorescent indicator, dihydroethidium) in Ca(2+)-permeabilized, pressurized small pulmonary arteries. These latter responses to CH were prevented by general inhibition of NOX isoforms (apocynin, diphenylene iodonium), and by selective inhibition of NOX 2 (gp91ds-tat), Rac1 (NSC 23766), and EGFR (AG 1478). Consistent with these observations, CH increased KCl-induced EGFR phosphorylation, and augmented depolarization-induced Rac1 activation in an EGFR-dependent manner. INNOVATION: This study establishes a novel signaling axis in VSM linking membrane depolarization to contraction that is independent of Ca(2+) influx, and which mediates myofilament Ca(2+) sensitization in the hypertensive pulmonary circulation. CONCLUSION: CH augments membrane depolarization-induced pulmonary VSM Ca(2+) sensitization and vasoconstriction through EGFR-dependent stimulation of Rac1 and NOX 2.
Authors: Nikki L Jernigan; Lindsay M Herbert; Benjimen R Walker; Thomas C Resta Journal: Am J Physiol Cell Physiol Date: 2011-12-28 Impact factor: 4.249
Authors: R Bierer; C H Nitta; J Friedman; S Codianni; S de Frutos; J A Dominguez-Bautista; T A Howard; T C Resta; L V Gonzalez Bosc Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-09-09 Impact factor: 5.464
Authors: Gábor Csányi; Eugenia Cifuentes-Pagano; Imad Al Ghouleh; Daniel J Ranayhossaini; Loreto Egaña; Lucia R Lopes; Heather M Jackson; Eric E Kelley; Patrick J Pagano Journal: Free Radic Biol Med Date: 2011-04-17 Impact factor: 7.376
Authors: Mo-Jun Lin; George P H Leung; Wei-Min Zhang; Xiao-Ru Yang; Kay-Pong Yip; Chung-Ming Tse; James S K Sham Journal: Circ Res Date: 2004-07-15 Impact factor: 17.367
Authors: Timothy D Le Cras; William D Hardie; Karen Fagan; Jeffrey A Whitsett; Thomas R Korfhagen Journal: Am J Physiol Lung Cell Mol Physiol Date: 2003-08-01 Impact factor: 5.464
Authors: Feng Chen; Xueyi Li; Emily Aquadro; Stephen Haigh; Jiliang Zhou; David W Stepp; Neal L Weintraub; Scott A Barman; David J R Fulton Journal: Free Radic Biol Med Date: 2016-08-03 Impact factor: 7.376
Authors: Olga Rafikova; Ruslan Rafikov; Archana Kangath; Ning Qu; Saurabh Aggarwal; Shruti Sharma; Julin Desai; Taylor Fields; Britta Ludewig; Jason X-Y Yuan; Danny Jonigk; Stephen M Black Journal: Free Radic Biol Med Date: 2016-02-27 Impact factor: 7.376
Authors: Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan Journal: Am J Physiol Lung Cell Mol Physiol Date: 2014-07-03 Impact factor: 5.464
Authors: Laura Weise-Cross; Michelle A Sands; Joshua R Sheak; Brad R S Broughton; Jessica B Snow; Laura V Gonzalez Bosc; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta Journal: Am J Physiol Heart Circ Physiol Date: 2018-01-26 Impact factor: 4.733
Authors: Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-03-08 Impact factor: 5.464
Authors: Juan Manuel Ramiro-Diaz; Wieslawa Giermakowska; John M Weaver; Nikki L Jernigan; Laura V Gonzalez Bosc Journal: Am J Physiol Cell Physiol Date: 2014-08-27 Impact factor: 4.249